Description
FOR ANIMAL USE ONLY
BOVI-TECT P
Reg. No. G3002 (Act 36/1947)
Namibia Reg. No. V02/24.4/689 [NS0]
INDICATIONS
The vaccine reduces the incidence of morbidity and mortality caused by undifferentiated bovine respiratory disease (pasteurellosis) associated with M. (Pasteurella) haemolytica.
This vaccine is also recommended for inclusion in a vaccination programme for feedlot cattle at processing.
COMPOSITION
Cell free supernatant of Mannheimia (Pasteurella) haemolytica biotype A serotype 1/17 leukotoxin vaccine for cattle.
For optimal use, consult your veterinarian.
